Pipeline

In EME, we have been approaching Unmet medical needs with our technologies. We have six pipeline categories; solid cancer, cancer immunotherapies, infectious disease, respiratory disease, neurologic disease, and lifestyle related disease.

* June, 2023

Solid Cancer

EME Code #LibraryTargetDevelopment Stage
screeningOptimizationPre-Clinical TrialClinical Trial
Hit*Lead*In vitroIn vivo
EME003VHHPancreatic Cancer
EME005VHHBreast Cancer
EME006VHHLiver Cancer
EME014VHHPancreatic Cancer Esophageal Cancer

*Hit compound **Lead compound

* June, 2023

Cancer Immunotherapy

EME Code #LibraryTargetDevelopment Stage
screeningOptimizationPre-Clinical TrialClinical Trial
Hit*Lead*In vitroIn vivo
EME018VHHImmune Check point

*Hit compound **Lead compound

* June, 2023

Infectious Disease

EME Code #LibraryTargetDevelopment Stage
screeningOptimizationPre-Clinical TrialClinical Trial
Hit*Lead*In vitroIn vivo
EME018VHHCovid-19

*Hit compound **Lead compound

* June, 2023

Respiratory Disease

EME Code #LibraryTargetDevelopment Stage
screeningOptimizationPre-Clinical TrialClinical Trial
Hit*Lead*In vitroIn vivo
EME020VHHAsthma

*Hit compound **Lead compound

* June, 2023

Neurologic Disease

EME Code #LibraryTargetDevelopment Stage
screeningOptimizationPre-Clinical TrialClinical Trial
Hit*Lead*In vitroIn vivo
EME023VHHALS Parkinson Disease

*Hit compound **Lead compound

* June, 2023

Lifestyle related Disease

EME Code #LibraryTargetDevelopment Stage
screeningOptimizationPre-Clinical TrialClinical Trial
Hit*Lead*In vitroIn vivo
EME008VHHNASH

*Hit compound **Lead compound

* June, 2023

Related Contents

 

Product&Pipeline

 
Contact Us

If you have any questions about our service/need more information about joint research or licesing business, please feel free to contact us via the contact form below.